Topical Photodynamic Therapy Using Intense Pulsed Light for Treatment of Actinic Keratosis: Clinical and Histopathologic Evaluation
|
|
- Kellie Shaw
- 5 years ago
- Views:
Transcription
1 Topical Photodynamic Therapy Using Intense Pulsed Light for Treatment of Actinic Keratosis: Clinical and Histopathologic Evaluation HYUNG SU KIM, MD,JONG YEOP YOO, MD,KWANG HYUN CHO, MD,OH SANG KWON, MD, AND SANG EUN MOON, MD Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea BACKGROUND. Photodynamic therapy (PDT) is suitable for the treatment of actinic keratosis, and, recently, topical PDT using intense pulsed light as a light source has been reported. However, evaluations of its therapeutic effects have been clinically based. OBJECTIVE. The objective of this study was to confirm the histopathologic resolution of actinic keratosis treated by topical PDT using intense pulsed light as a light source. METHODS. Twelve actinic keratosis lesions in seven patients were treated with 5-aminolevulinic acid PDT using intense pulsed light as a light source. After a single treatment, the clinical response was assessed and histopathologic examinations were performed on clinically resolved lesions. RESULTS. Six of 12 (50%) lesions showed clinical clearance after a single treatment, but histologic examinations showed that only 5 of the 12 (42%) lesions had been removed. No complications, such as pigmentary changes or scarring, were observed. CONCLUSION. Intense pulsed light is potentially an effective light source for PDT. However, the determination of complete remission in actinic keratosis requires caution, and long-term follow-up or histologic confirmation may be required. HYUNG SU KIM, MD, JONG YEOP YOO, MD, KWANG HYUN CHO, MD, OH SANG KWON, MD, AND SANG EUN MOON, MD, HAVE INDICATED NO SIGNIFICANT INTEREST WITH COMMERCIAL SUPPORTERS. PHOTODYNAMIC THERAPY (PDT) is a noninvasive technique that is used to treat many skin diseases. Various combinations of photosensitizers and light sources are used. The most commonly used photosensitizer in dermatology is topical 5-aminolevulinic acid (ALA), and many incoherent lights and lasers are used as light sources. 1 6 Actinic keratosis is a relatively common skin disorder and has the potential to progress to squamous cell carcinoma, and it is a well-known candidate for PDT. Several studies have found that ALA-PDT using an intense pulsed light as a light source clinically improves actinic keratosis, but these results were not proven histopathologically. 7,8 Thus, in the present study, we investigated the histopathologic degree of resolution achieved by topical PDT using intense pulsed light in actinic keratosis. Patients and Methods Seven Korean patients with actinic keratosis, who had been confirmed histologically, were enrolled in this Address correspondence and reprint requests to: Sang Eun Moon, MD, Department of Dermatology, Seoul City Boramae Hospital, 395 Shindaebang 2-dong, Dongjak-gu, Seoul , Korea, or semoon@snu.ac.kr. study. Two were male and five were female. Their mean age was 69.7 years, ranging from 60 to 85 years. There were 12 lesions ranging from cm to cm (Table 1). Just prior to applying topical ALA cream, we removed the lesion crust and tape-stripped the lesion. Twenty percent ALA (Sigma, St Louis, MO, USA) was mixed in an oil-in-water emulsion 9 and applied to the lesion concerned 4 hours prior to treatment as a thick layer (0.2 g/cm 2 ). A plastic film was placed over the ALA cream to increase penetration. The light source used was an Ellipse Flex (Danish Dermatologic Development, Hoersholm, Denmark), which emits a flashlamp-stimulated noncoherent light that is dually filtered to wavelengths from 555 to 950 nm. The dual-mode filtering used in this system removes clinically nonrelevant wavelengths above 950 nm. The fluence was 12 to 16 J/cm 2, and the pulse duration was 20 to 30 ms. Two passages of irradiation were done (Table 2). Patients visited 2, 8, and 12 weeks after treatment. At each follow-up visit, adverse events were checked. At 8 or 12 weeks after treatment, the effect of PDT was evaluated. Subjective evaluations were performed by self-scoring improvement from 0 (no improvement) to 10 (complete improvement). Two investigators evaluated lesion improvement as excellent (100%), good r 2005 by the American Society for Dermatologic Surgery, Inc. ISSN: Dermatol Surg 2005;31:33 37 Published by BC Decker Inc.
2 34 KIM ET AL: TOPICAL PHOTODYNAMIC THERAPY USING PULSED LIGHT Dermatol Surg 31:1:January 2005 Table 1. Clinical Profiles of Patients Case Age Sex Site of Lesions Number of Lesions Size, cm M Nose F Nose F Both temples, n nose, cheek 4 72 F Both temples n 5 67 F Cheek F Cheek M Nose tip n Size of the largest lesion. (50 99%), fair to poor (1 49%), or none (0%). If a lesion showed an excellent response, a skin biopsy was performed to confirm whether the actinic keratosis had been resolved. When actinic keratosis clinically showed residual lesion or a skin biopsy proved that the lesion remained, we conducted the next PDT. Results Clinical Evaluation The treatment was generally well tolerated, although some patients experienced tolerable pain during the irradiation procedure. Immediately after treatment, erythema and mild edema were seen in all lesions, with crusting followed by uncomplicated healing in 2 or 3 weeks. After a single treatment, five patients were subjectively assessed to have achieved complete improvement. Objectively, an excellent clinical improvement was observed in 6 of the 12 lesions (see Table 2 and Figure 1). Two lesions in case 4 showed good Table 2. Therapeutic Effect after First Treatment Case Pulse Residual Energy, Duration, Subjective Objective Lesion J/cm 2 ms Evaluation Evaluation, % on Biopsy Dropped out Not done n n After second session of photodynamic therapy. Figure 1. (A) Pretreatment. A well-demarcated scaly erythematous patch was found on the cheek. (B) Post-treatment. The actinic keratosis was completely resolved. improvement with clinical residual actinic keratosis and therefore received a second session of PDT. Four lesions in one patient (case 3) achieved a poor response, and the patient opted for another treatment modality; follow-up PDT was not performed in this case. No complications, such as pigmentary changes or scarring, were observed. In summary, 6 of 12 lesions showed clinical resolution after a single treatment. Histopathologic Evaluation A post-treatment skin biopsy was done in the six lesions that achieved an excellent clinical response. PDT caused the disappearance of abnormal keratinocytes from the epidermis, but one lesion revealed atypical cells in the follicular infundibulum (Figure 2). Pretreatment histopathologic findings were compared between actinic keratosis that completely responded and actinic keratosis that failed to respond to treatment. The failed lesions showed more severe change and a moderately thickened epidermis and hyperkeratosis. Atypical cells were present up to the upper part of the epidermis (Figure 3). In summary, the histologic examination showed that 5 of 12 lesions had completely resolved (see Table 2). Discussion The response of actinic keratosis to ALA-PDT is equal to or better than the cure rates achieved using
3 Dermatol Surg 31:1:January 2005 KIM ET AL: TOPICAL PHOTODYNAMIC THERAPY USING PULSED LIGHT 35 Figure 3. Pretreatment histology of the lesion that failed to respond. Marked hyperkeratosis was observed, and abnormal cells were present to the upper epidermis (hematoxylin-eosin stain; original magnification 100). Figure 2. (A) Pretreatment. Atypical cells were found in the basal layer of the epidermis and in the follicular infundibulum (hematoxylineosin stain; original magnification 100). (B) Post-treatment. In the basal layer of the epidermis, no atypical cells were found. However, atypical cells were observed in the follicular infundibulum (hematoxylin-eosin stain; original magnification 100). conventional treatment modalities. ALA-PDT more selectively treats actinic keratosis and the surrounding normal skin and thus achieves better cosmetic results. 10,11 Various kinds of light source have been used for topical ALA-PDT. Intense pulsed light has been described as a light source for the PDT of actinic keratosis as part of photorejuvenation. 7,8 The intense pulsed light system emits a broad spectrum of visible to near-infrared light (500 1,300 nm) with high irradiation density and precisely applies light to target lesions. 12,13 Infrared radiation can cause hyperthermia and accordingly it is best to avoid it. However, some investigators have suggested that mild hyperthermia acts synergistically with PDT. 14 Photodynamically active products can also be generated at wavelengths beyond the activation spectrum of the endogenous photosensitizer protoporphyrin IX. These facts may indicate that broadband illumination at a high intensity may be a more effective light source for ALA-PDT. 15 With ALA-PDT using intense pulsed light as a light source, Ruiz-Rodriguez and colleagues reported a clinical resolution rate of 76.3% and Avram and Goldman reported that 68% of actinic keratosis lesions were resolved by a single treatment. 7,8 However, this evaluation was based on clinical inspections and photographs. Actually, in most studies that have investigated the effects of PDT, histopathologic confirmation of clearance was rarely undertaken. Recently, Calzavara-Pinton histopathologically observed persisting clinically nonvisible actinic keratosis in 3 of 17 apparently cleared lesions. 16 In our series, 6 of 12 lesions (50%) showed clinical resolution after single ALA-PDT, but a subsequent histopathologic examination showed that one of these 6 lesions contained residual atypical cells. The histopathologic finding that atypical keratinocytes remain in the follicular infundibulum in clinically cleared lesions may provide some suggestions that it may be foci of recurring in PDT. ALA can reach to the sebaceous gland, and photochemical reaction can occur at this level. 17 If insufficient reaction occurs for some reason, for example, owing to a melanin barrier or a low light dose, abnormal cells in the follicular infundibulum can survive and cause a recurrence. In addition, thick, hyperkeratotic actinic keratosis has been reported not to respond effectively to PDT, and the actinic keratosis lesions that failed to respond in our series support this finding. A reduced response may be related to ineffective penetration of ALA and resultant lack of PpIX conversion. 3,18 In several open studies of ALA-PDT on face or scalp actinic keratosis in whites, clearance rates
4 36 KIM ET AL: TOPICAL PHOTODYNAMIC THERAPY USING PULSED LIGHT Dermatol Surg 31:1:January 2005 were reported as 68 to 100% after a single treatment. 1 4,8,18 20 Our study, which was done on more pigmented Asian skins, showed a much lower clearance rate. In a Japanese series reported by Itoh and colleagues, the efficacy of ALA-PDT for actinic keratosis showed an 82% clearance rate for facial lesions, which required three to six treatment sessions. 21 The fact that multiple treatment sessions were required to achieve a higher clearance rate implies some ethnic differences in terms of response to topical PDT owing to skin color differences. Berstein and colleagues showed a reduced photodynamic effect in highly pigmented skin in a guinea pig model. 22 They believed that melanin might moderate the photodynamic effect by absorbing free radicals and light and suggested that skin color could influence PDT response. Thus, to increase the effect, higher light doses may be required, but there is no clear relationship between the complete remission rate and the dosage used. 14 From the results of the Japanese study, although a direct comparison is not possible because different light sources were used, it would appear that repeated treatment would have achieved a higher clearance rate in our series. In addition, we believe that further study is needed to define the appropriate dose. No adverse effects, such as pigmentary changes, were found in our series. This may be related to the small number of patients enrolled and single treatment session used. Adverse reactions are uncommonly encountered. Clark and colleagues reported that 2% of patients showed pigmentary change and 2% had scarring. 4 In conclusion, we believe that intense pulsed light is a potentially effective light source for ALA-PDT and that careful thought is needed concerning clinical response evaluation. References 1. Jeffers EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001;45: Karrer S, Barmler W, Abels C, et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999;25: Varma S, Wilson H, Kurwa HA, et al. Bowen s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001;144: Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003;19: Goldman MP, Atkin DH. ALA/PDT in the treatment of actinic keratosis: spot versus confluent therapy. J Cosmet Laser Ther 2003;5: Dijkstra AT, Majoie IM, van Dongen JW, et al. Photodynamic therapy with violet light and topical 5-aminolaevulinic acid in the treatment of actinic keratosis, Bowen s disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 2001;15: Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol Surg 2002;28: Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004;3 Suppl:S Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical d-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001;144: Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999;41: Morton CA. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J Dermatol Treat 2002; 13 Suppl 1:S Raulin C, Greve B, Grema H. IPL technology: a review. Lasers Surg Med 2003;32: Weiss RA, Weiss MA. Intense pulsed light: newer perspective. Dermatol Surg 1997;23: Peng Q, Warloe T, Berg C, et al. 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997;79: Kimel S, Svaasand LO, Hammer-Wilson M, et al. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model. Lasers Surg Med 1992;12: Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolevulinic acid as an appropriate approach to the routine treatment of superficial nonmelanoma skin tumors. J Photochem Photobiol B 1995;29: Hongcharu W, Taylor CR, Chang Y, et al. Topical ALAphotodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000;115: Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolaevulinic acid. Arch Dermatol 1997;133: Szeimes RM, Karrer S, Sauerwald A, Landthaler M. Photodynamic therapy with topical application of 5-aminolaevulinic acid in the treatment of actinic keratoses: an initial clinical study. Dermatology 1996;192: Wolf P, Rieger E, Kerl H. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas and basal cell carcinomas. J Am Acad Dermatol 1993;28: Itoh Y, Ninomiya Y, Henta T, et al. Topical delta-aminolevulinic acid-based photodynamic therapy for Japanese actinic keratoses. J Dermatol 2000;27: Berstein EF, Thomas GF, Smith PD, et al. Response of black and white guinea pig skin to photodynamic treatment using 514-nm light and dihematoporphyrin ether. Arch Dermatol 1990;126: Commentary The evolving practice of combining 5-aminolevulinic acid (ALA)-based photodynamic therapy (PDT) with intense pulsed light (IPL) holds many attractions. If it were possible to confirm the efficacy of IPL-PDT in the treatment of actinic keratoses (as well as basal cell carcinoma and Bowen s disease), then the convenience of treatment would be greatly enhanced. Instead of illumination times of 8 to 20 minutes with currently available light sources, the time could be reduced to a matter of seconds. The Holy Grail might be to find a formulation of ALA that requires only 30 minutes or less of application to be photoactive. Penetration-enhancing bases such as pluronic lecithin organogel might hold some promise in this regard. 1 An IPL- PDT treatment could then be completed well inside an hour, with only one visit a distinct advantage over the present situation.
5 Dermatol Surg 31:1:January 2005 KIM ET AL: TOPICAL PHOTODYNAMIC THERAPY USING PULSED LIGHT 37 Currently, level 1A evidence exists from randomized controlled studies of the superior effectiveness of PDT using methyl- ALA and red light in the treatment of actinic keratoses when compared with cryotherapy or placebo. 2 Such evidence does not yet exist for IPL when used as the light source. The concept is nonetheless promising because there would be no need to have a dedicated PDT light source and the treatment could be routinely combined with IPL photorejuvenation. The second-generation IPL reported in this article used a wavelength band of 555 to 950 nm, thereby eliminating the longer infrared light from 950 to 1,200 nm found in most firstgeneration IPLs. The median wavelength of the power spectrum for the 555 to 950 nm band is positioned at 726 nm. 3 Given that one of the favored light activation bands for protoporphyrin IX (the photoactive porphyrin that results from application of ALA) is around 630 nm, the benefit of such broad-spectrum light from IPL is perhaps somewhat questionable. A more restricted wavelength band from 530 to 750 nm, which is available from the same manufacturer reported in this article, has a median wavelength at 660 nm, 3 which is much closer to the 630 nm absorption peak for protoporphyrin IX. It would be very interesting to investigate the effectiveness of the narrower spectrum for this application. The use of IPL in darker skin types is contentious, and the lack of complications in this small study is intriguing. At a theoretic level, one can anticipate significant potential for blistering and postinflammatory hyperpigmentation. When dealing with actinic keratoses, it is likely that more epidermal and dermal heating is required to ablate the dysplastic epidermis. The size of the actinic keratoses in this study raises the possibility of a diagnosis of Bowen s disease, and it is certainly relevant that those actinic keratoses that failed to clear were more hyperkeratotic. Repeated treatment, as suggested by the authors, is probably necessary to improve efficacy. It would be surprising if this report were not followed by a flurry of research activity with IPL-PDT looking at the whole range of variables, with both photosensitizers and IPL dosing. References CARL VINCIULLO, MB, BS, FACD Perth, Western Australia 1. Jones M. The history of pluronic lecithin organogel. Int J Pharmaceut Compound 2003;7: Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate with single cycle cryotherapy in patients with actinic keratosis: a prospective randomized study. J Dermatol Treat 2003;14: Bjerring P, Christiansen K, Troilus A, et al. Facial photo rejuvenation using two different intense pulsed light wavelength bands. Lasers Surg Med 2004;34:120 6.
1) Photodynamic therapy with topical 5 aminolevulinic acid is considered medically necessary and is covered for the treatment of:
Medical Policy Title: Photodynamic Therapy ARBenefits Approval: 10/26/2011 for Dermatologic Conditions Effective Date: 01/01/2012 Document: ARB0282:02 Revision Date: 03/20/2013 Code(s): 96567 Photodynamic
More informationSTUDY. Laser-Mediated Photodynamic Therapy of Actinic Keratoses
STUDY Laser-Mediated Photodynamic Therapy of Actinic Keratoses Macrene R. Alexiades-Armenakas, MD, PhD; Roy G. Geronemus, MD Objective: To assess the safety and efficacy of the longpulsed pulsed dye laser
More informationA Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy according to the Density of Ablative Laser Channel
A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy according to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis Yeo-Rye Cho, Jeong-Hwan
More informationDual Wavelength Phototherapy System
Dual Wavelength Phototherapy System The AKLARUS Blue and Red Combination System is an effective, drugfree alternative for treating acne & photodamaged skin. The non-invasive Aklarus treatment has been
More informationPhotodynamic Photorejuvenation: An 18- month Experience on Combination of ALA-IPL and a 630nm LED Continuous Light Source
Photodynamic Photorejuvenation: An 18- month Experience on Combination of ALA-IPL and a 630nm LED Continuous Light Source by Samuel Seit MBBS Neutral Bay, Sydney, Australia ABSTRACT Photodynamic therapy
More informationPhotodynamic Therapy with Ablative Carbon Dioxide Fractional Laser in Treatment of Actinic Keratosis
PDT with Ablative CO 2 Fractional Laser for AK Ann Dermatol Vol. 25, No. 4, 2013 http://dx.doi.org/10.5021/ad.2013.25.4.417 ORIGINAL ARTICLE Photodynamic Therapy with Ablative Carbon Dioxide Fractional
More informationPhotodynamic Therapy with Ablative Carbon Dioxide Fractional Laser for Treating Bowen Disease
Ann Dermatol Vol. 25, No. 3, 2013 http://dx.doi.org/10.5021/ad.2013.25.3.335 ORIGINAL ARTICLE Photodynamic Therapy with Ablative Carbon Dioxide Fractional Laser for Treating Bowen Disease Sue Kyung Kim,
More informationAn Open-Label, Split-Face Trial Evaluating Efficacy and Safty of Photopneumatic Therapy for the Treatment of Acne
Ann Dermatol Vol. 24, No. 3, 2012 http://dx.doi.org/10.5021/ad.2012.24.3.280 ORIGINAL ARTICLE An Open-Label, Split-Face Trial Evaluating Efficacy and Safty of Photopneumatic Therapy for the Treatment of
More informationThai Journal of Pharmaceutical Sciences (TJPS)
Thai Journal of Pharmaceutical Sciences (TJPS) 34 th International Annual Meeting in Pharmaceutical Sciences and 2 nd CU FPhS - RIKEN CDB Symposium (IAMPS34 and 2nd CU FPhS - RIKEN CDB) Photodynamic therapy
More informationCorporate Medical Policy
Corporate Medical Policy Dermatologic Applications of Photodynamic Therapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dermatologic_applications_of_photodynamic_therapy 10/2003
More informationField vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM
Dilemmas and Challenges in Skin Cancer Therapies and Management Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM Roger I. Ceilley, M.D. Clinical Professor of Dermatology The University of Iowa
More informationNO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD
NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD KEY POINTS Hispanics/Latinos are the fastest growing segment of the skin of color population Use
More informationNSC B
NSC89 2314 B 006 095 88 8 1 89 7 31 E-mail twwong@mail.ncku.edu.tw 89 09 17 1 The Sequential Studies of Photodynamic Therapy: Development of Optimal Transdermal Delivery Agent and The Fluorescence Monitor
More informationPartial Unilateral Lentiginosis Treated with 532-nm and Subsequent Low-Fluence 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Lasers
OCT-2016 ISSUE Med Laser 2016;5(1):42-46 pissn 2287-8300 ㆍ eissn 2288-0224 Partial Unilateral Lentiginosis Treated with 532-nm and Subsequent Low-Fluence 1,064-nm Q-Switched Neodymium-Doped Yttrium Aluminum
More informationNONABLATIVE RESURFACING
`AESTHETIC LASER SURGERY 0094-1298/00 $15.00 +.00 NONABLATIVE RESURFACING David J. Goldberg, MD TYPES OF LASERS AND THEIR DIFFERENCES Pulsed char-free CO2 laser skin resurfacing has provided a method of
More informationWith expanding indications for the use of photodynamic. Photodynamic Therapy: Indications and Treatment. Review Article
Review Article Continuing Medical Education Article Skin Treatment Photodynamic Therapy: Indications and Treatment Michael H. Gold, MD Learning Objectives: The reader is presumed to have a broad understanding
More informationResearch Article 1,213 Cases of Treatment of Facial Acne Using Indocyanine Green and Intense Pulsed Light in Asian Skin
BioMed Research International Volume 2015, Article ID 596161, 5 pages http://dx.doi.org/10.1155/2015/596161 Research Article 1,213 Cases of Treatment of Facial Acne Using Indocyanine Green and Intense
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationA Retrospective Study of Treatment of Squamous Cell Carcinoma In situ. Övermark, Meri.
https://helda.helsinki.fi A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ Övermark, Meri 2016 Övermark, M, Koskenmies, S & Pitkanen, S 2016, ' A Retrospective Study of Treatment of
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationPhotodynamic Therapy (PDT) Basics and clinical applications
Photodynamic Therapy () Basics and clinical applications D. Roseeuw, S. T kint Department of Dermatology UZBrussel - VUB GOAL of : selective destruction of targeted abnormal cells Light O 2 Photosensitiser
More informationPRODUCT INFORMATION METVIX
PRODUCT INFORMATION METVIX NAME OF THE MEDICINE Methyl aminolevulinate (as hydrochloride). Structural formula: O OCH 3 NH 3 + Cl - O CAS number: 79416-27-6 DESCRIPTION Metvix cream contains 160 mg/g of
More informationLow-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064nm) laser for the treatment of facial melasma in local population
Original Article Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064nm) laser for the treatment of facial melasma in local population Tahir Kamal, Usma Iftikhar* Department of Dermatology,
More informationModified 3-Step Broadband Light Treatment for Inflammatory Acne Vulgaris and Post-Acne Erythema in Asian Patients
Case Report Med Laser 2017;6(2):102-106 https://doi.org/10.25289/ml.2017.6.2.102 pissn 2287-8300 ㆍ eissn 2288-0224 Modified 3-Step Broadband Light Treatment for Inflammatory Acne Vulgaris and Post-Acne
More informationMulti-Application Platform. Summary of Peer-reviewed Articles for Various Clinical Indications April 2016
Multi-Application Platform Summary of Peer-reviewed Articles for Various Clinical Indications April 2016 Various Clinical Indications Atrophic acne scars and acne Photo-aged skin, pigmentation & hyperpigmentation
More informationDermatologic Applications of Photodynamic Therapy
Dermatologic Applications of Photodynamic Therapy Policy Number: 2.01.44 Last Review: 3/2014 Origination: 8/2007 Next Review: 3/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationPDT in Medical and Aesthetic Dermatology: An European Perspective. Rolf-Markus Szeimies Recklinghausen, Germany
PDT in Medical and Aesthetic Dermatology: An European Perspective Rolf-Markus Szeimies Recklinghausen, Germany DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Rolf-Markus Szeimies, MD PhD F066 Photodynamic Therapy
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationAllergic contact dermatitis to topical prodrugs used in photodynamic therapy Cordey, Helen; Ibbotson, Sally
University of Dundee Allergic contact dermatitis to topical prodrugs used in photodynamic therapy Cordey, Helen; Ibbotson, Sally Published in: Photodermatology, Photoimmunology & Photomedicine DOI: 10.1111/phpp.12252
More informationSTUDY. Topical 5-Aminolevulinic Acid Combined With Intense Pulsed Light in the Treatment of Photoaging
STUDY Topical 5-Aminolevulinic Acid Combined With Intense Pulsed Light in the Treatment of Photoaging Jeffrey S. Dover, MD, FRCPC; Ashish C. Bhatia, MD; Brigitte Stewart; Kenneth A. Arndt, MD Background:
More informationCLINICAL REPORT MATERIALS AND METHODS. Acta Derm Venereol 2005; 85:
Acta Derm Venereol 2005; 85: 424 428 CLINICAL REPORT A Randomized Multicenter Study to Compare Two Treatment Regimens of Topical Methyl Aminolevulinate (Metvix H )-PDT in Actinic Keratosis of the Face
More informationMedical Policy. MP Dermatologic Applications of Photodynamic Therapy
Medical Policy MP 2.01.44 BCBSA Ref. Policy: 2.01.44 Last Review: 12/27/2017 Effective Date: 12/27/2017 Section: Medicine Related Policies 2.01.47 Light Therapy for Psoriasis 8.01.06 Oncologic Applications
More informationFractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses COS DERM
Case Report Fractional CO 2 Laser Skin Resurfacing for the Treatment of Sun-Damaged Skin and Actinic Keratoses LindaSusan Marcus, MD; Neal Carlin, BS; Robert Carlin, BS, MA It is important to realize that
More informationScottish Medicines Consortium
Scottish Medicines Consortium imiquimod 5% cream (Aldara) No. (385/07) Meda Pharmaceuticals Ltd 04 April 2008 The Scottish Medicines Consortium has completed its assessment of the above product and advises
More informationReports on Scientific Meeting
Hong Kong J. Dermatol. Venereol. (2005) 13, 102-106 63rd Annual Meeting, American Academy of Dermatology Reported by LS Chiu Date: 22 February, 2005 Venue: New Orleans, Louisiana, USA Organiser: American
More information5-ALA Photopreparation Using Pulsed NIR Enhances Skin Fluorescence via Temperature-Independent Cell Signaling Pathways
5-ALA Photopreparation Using Pulsed NIR Enhances Skin Fluorescence via Temperature-Independent Cell Signaling Pathways Augustin C. Barolet a,b, Gregory Cormack b, Daniel Barolet b,c a Polytechnique Montreal,
More informationHands-on: Lasers. NonAblative Rejuvenation
Hands-on: Lasers NonAblative Rejuvenation Anthony M. Rossi, MD Assistant Attending Memorial Sloan Kettering Cancer Center Assistant Professor Weill Cornell Medical College DISCLOSURE OF RELEVANT RELATIONSHIPS
More informationRightLight TM Technology Enhanced Dye Wavelengths. WHITE PAPER Synchro VasQ
RightLight TM Technology Enhanced Dye Wavelengths WHITE PAPER Synchro VasQ DEKA White Paper SYNCHRO VASQ February 2013 RightLight TM Technology Enhanced Dye Wavelengths Prof. P. Campolmi, Prof. G.Cannarozzo,
More informationDERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY
DERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
More informationDiagnosis and Management of Actinic Keratosis (AKs)
Diagnosis and Management of Actinic Keratosis (AKs) Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada
More informationLaser Treatment of Leg Veins
Laser Treatment of Leg Veins Updated: Sep 17, 2015 Author: Mitchel P Goldman, MD; Chief Editor: Dirk M Elston, MD more... Overview Background Public interest in laser and light treatment of leg veins is
More informationDiode Laser-Mediated ALA-PDT Guided by Laser-Induced Fluorescence Imaging
Diode Laser-Mediated ALA-PDT Guided by Laser-Induced Fluorescence Imaging af Klinteberg, C; Wang, I; Karu, I; Johansson, Thomas; Bendsöe, Niels; Svanberg, Katarina; Andersson-Engels, Stefan; Svanberg,
More informationThe Sonic Hedgehog Pathway
To Print: Click your browser's PRINT button. NOTE: To view the article with Web enhancements, go to: http://www.medscape.com/viewarticle/521045 Conference Report Highlights of the Combined Annual Meeting
More informationF066: Photodynamic Therapy in Medical and Aesthetic Dermatology
F066: Photodynamic Therapy in Medical and Aesthetic Dermatology Improving Efficacy and Maintaining Safety of ALA-PDT American Academy of Dermatology 77 th Annual Meeting Washington, DC Maria M. Tsoukas,
More informationHave a Voice in Your Choice!
Have a Voice in Your Choice! BLU-U Blue Light Photodynamic Therapy The LEVULAN KERASTICK for Topical Solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is
More informationHow I Use Photodynamic Therapy with 5-Aminolevulinic Acid in My Clinical Practice
How I Use Photodynamic Therapy with 5-Aminolevulinic Acid in My Clinical Practice Dore J. Gilbert Newport Dermatology and Laser Associates, Newport Beach, Calif., USA Abstract Since the early 1990s, the
More informationNon-Ablative Rejuvenation
Non-Ablative Rejuvenation Denise Baker, MD Non-Ablative Skin Rejuvenation Denise Baker, MD The following potential conflict of interest relationships are germane to my presentation. Intrinsic Aging Inevitably
More informationOpinion 6 March 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 6 March 2013 EFFALA 8 mg, medicated plaster B/4 sachets (CIP code: 34009 397 996 4 3) B/8 sachets (CIP code: 34009
More informationAvailable online at Vol. 07, No. 02, pp , February, 2018 RESEARCH ARTICLE
z Available online at http://www.ijcrls.com International Journal of Current Research in Life Sciences Vol. 07, No. 02, pp.1139-1143, February, 2018 ISSN: 2319-9490 RESEARCH ARTICLE THE TREATMENT OF DILATED
More informationDual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background
Dual wavelength (1540nm + 10600 nm) mixed technology for fractional resurfacing in skin rejuvenation Dr. Paolo Sbano, M.D. Specialist in Dermatology and Venereology Department of Dermatology of Belcolle
More informationAcne Treatments using the SharpLight s AC415 nm Handpiece Conducted by: Kipnis MD, A.M.L. Institute, Israel
Acne Treatments using the SharpLight s AC415 nm Handpiece Conducted by: Kipnis MD, A.M.L. Institute, Israel Introduction Acne is a chronic disease of the pilosebaceous follicle and is the most common skin
More informationEfficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study
DOI: 10.1111/j.1468-3083.2011.04039.x JEADV ORIGINAL ARTICLE Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study M.M. Kleinpenning,* M.E. Otero,
More informationACNE IS A COMMON DISORder,
ORIGINAL ARTICLE Evaluation of Acne Scar Treatment With a 1450-nm Midinfrared Laser and 30% Trichloroacetic Acid Peels Paul J. Carniol, MD; Jyothi Vynatheya; Eric Carniol Objective: To evaluate the efficacy
More informationDevelopment of Low-Cost Photodynamic Therapy Device
Vol. 112 (2007) ACTA PHYSICA POLONICA A No. 5 Proceedings of the International School and Conference on Optics and Optical Materials, ISCOM07, Belgrade, Serbia, September 3 7, 2007 Development of Low-Cost
More informationComparison of PpIX accumulation and destruction during. methyl-aminolevulinate photodynamic therapy (MAL-PDT) of
Comparison of PpIX accumulation and destruction during methyl-aminolevulinate photodynamic therapy (MAL-PDT) of skin tumours located at acral and non-acral sites J. S. Tyrrell 1, C Morton 2, S. M. Campbell
More informationPhotodamaged skin occurs as a result of its
Plasma Skin Resurfacing for Regeneration of Neck, Chest, and Hands: Investigation of a Novel Device TINA S. ALSTER, MD, AND SAILESH KONDA, BS BACKGROUND Many noninvasive treatments to rejuvenate photodamaged
More informationA by-the-numbers assessment of therapies considers efficacy, convenience, cosmesis, and cost. By Amy Forman Taub, MD
A by-the-numbers assessment of therapies considers efficacy, convenience, cosmesis, and cost. By Amy Forman Taub, MD 8 Practical Dermatology February 007 Multiple treatment approaches exist for actinic
More informationDermatologic Applications of Photodynamic Therapy Corporate Medical Policy
Dermatologic Applications of Photodynamic Therapy Corporate Medical Policy File name: Dermatologic Applications of Photodynamic Therapy File code: UM.SURG.14 Last Review: 08/2016 Next Review: 08/2017 Effective
More informationActinic keratosis (AK): Dr Sarma s simple guide
Actinic keratosis (AK): Dr Sarma s simple guide Actinic keratosis is a very common lesion that you will see in your day-to-day practice. First, let me explain the name Actinic keratosis. It means keratosis
More informationAnn Dermatol Vol. 26, No. 3,
Ann Dermatol Vol. 26, No. 3, 2014 http://dx.doi.org/10.5021/ad.2014.26.3.321 ORIGINAL ARTICLE Comparative Study of Photodynamic Therapy with Topical Methyl Aminolevulinate versus 5-Aminolevulinic Acid
More informationGeneral information about skin cancer
Skin Cancer General information about skin cancer Key points Skin cancer is a disease in which malignant (cancer) cells form in the tissues of the skin. There are different types of cancer that start in
More informationRecent Trend in the Incidence of Premalignant and Malignant Skin Lesions in Korea between 1991 and 2006
J Korean Med Sci 2010; 25: 924-9 ISSN 1011-8934 DOI: 10.3346/jkms.2010.25.6.924 Recent Trend in the Incidence of Premalignant and Malignant Skin Lesions in Korea between 1991 and 2006 We evaluated the
More informationI have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: April 15, 2017 Related Policies 2.01.47 Light Therapy for Psoriasis 5.90.21 Aminolevulinic Acid 8.01.06 Oncologic Applications of Photodynamic Therapy, Including
More informationfluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A.
fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationCase Report No-Needle Jet Intradermal Aminolevulinic Acid Photodynamic Therapy for Recurrent Nodular Basal Cell Carcinoma of the Nose: A Case Report
Skin Cancer Volume 0, Article ID 790509, 5 pages doi:0.55/0/790509 Case Report No-Needle Jet Intradermal Aminolevulinic Acid Photodynamic Therapy for Recurrent Nodular Basal Cell Carcinoma of the Nose:
More informationRandomized Controlled Trial: Comparative Efficacy for the Treatment of Facial Telangiectasias With 532 nm Versus 940 nm Diode Laser
Lasers in Surgery and Medicine 41:555 562 (2009) Randomized Controlled Trial: Comparative Efficacy for the Treatment of Facial Telangiectasias With Versus Diode Laser Emily Tierney, MD 1,2 and C. William
More informationMULTIDIODE PDT 630 TM
MULTIDIODE PDT 630 TM DERMA Photodynamic therapy with 630nm laser Intralesional and percutaneous photodynamic therapy with PDT 630nm laser for benign and precancerous skin lesions MULTIDIODE PDT 630 TM
More informationAWMSG SECRETARIAT ASSESSMENT REPORT. 5-aminolaevulinic acid (Ameluz ) 78 mg/g gel. Reference number: 1074 FULL SUBMISSION
AWMSG SECRETARIAT ASSESSMENT REPORT 5-aminolaevulinic acid (Ameluz ) 78 mg/g gel Reference number: 1074 FULL SUBMISSION This report has been prepared by the All Wales Therapeutics and Toxicology Centre
More informationDermatologic Applications of Photodynamic Therapy Corporate Medical Policy
Dermatologic Applications of Photodynamic Therapy Corporate Medical Policy File name: Dermatologic Applications of Photodynamic Therapy File code: UM.SURG.14 Origination: 08/2016 Last Review: 01/2018 Next
More informationDermatologic Applications of Photodynamic Therapy
Page: 1 of 15 Last Review Status/Date: March 2015 Description Photodynamic therapy (PDT) refers to light activation of a photosensitizer to generate highly reactive intermediaries, which ultimately cause
More informationFluorescence Diagnosis For Follow- Up Of Mycosis Fungoides Therapy
Fluorescence Diagnosis For Follow- Up Of Mycosis Fungoides Therapy Bosseila M*, Al-Helf F, El-Sayed A, Mahgoub D*, Metwally D*, El-Shaer M Dermatology Dept*, Cairo Univ., Dermatology Dept, National Research
More informationChapter 21: FotoFacial RF Pro Treatment of Specific Clinical Subtypes
Chapter 21: FotoFacial RF Pro Treatment of Specific Clinical Subtypes 1. Erythema in Skin Types 1-3 (with or without Flushing, Laxity and Wrinkles) using the SR/SRA Head 116 The program usually takes 5-7
More informationConventional ablative carbon dioxide (CO 2 ) and
Lower-Fluence, Higher-Density versus Higher-Fluence, Lower-Density Treatment with a 10,600-nm Carbon Dioxide Fractional Laser System: A Split-Face, Evaluator-Blinded Study JIN YOUNG JUNG, MD, JU HEE LEE,
More informationJUST SEE ME! PIGMENTATION SOLUTIONS FOR HIGHER FITZPATRICKS
1 2 3 JUST SEE ME! PIGMENTATION SOLUTIONS FOR HIGHER FITZPATRICKS Just See Me! Diversity AESTHETICS Training! 20+ years! Advanced Aesthetics Diversity Consultant and Trainer! Professional Speaker! Aesthetic
More informationClearSkin. Er:Glass 1540nm Laser Module. Orly Baror Gal, Eng.BioMedical. Clinical Applications Specialist
ClearSkin Er:Glass 1540nm Laser Module Orly Baror Gal, Eng.BioMedical Clinical Applications Specialist Acne - Introduction 2 Acne Vulgaris Very common Affects 80% of the population Almost every person
More informationHigh Power CO2 Laser + Micro-needle Fractional RF
High Power CO2 Laser + Micro-needle Fractional RF Micro-needle RF Gynolaser (Optional) CO2 Laser What is Fraxis Duo? Fraxis Duo combines CO2 laser and micro-needle fractional RF technology for optimal
More informationRESERVE THIS SPACE. Development of LD 3 Wavelength Pulsed Laser for PDD and PDT Norio Miyoshi 1, Andriana B. Bibin 1, Kyo Kume 2 and Kotaro Tsutsumi 3
Chapter 3 RESERVE THIS SPCE Development of LD 3 Wavelength Pulsed Laser for PDD and PDT Norio Miyoshi 1, ndriana B. Bibin 1, Kyo Kume 2 and Kotaro Tsutsumi 3 1 Divission of Tumor Pathology, Faculty of
More informationSTUDY. Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgery for Nodular Basal Cell Carcinoma
STUDY Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgery for Nodular Basal Cell Carcinoma Results of a Multicenter Randomized Prospective Trial Lesley E. Rhodes, MD, FRCP; Menno de Rie,
More informationIntroduction. Device Description. Dual-Band Spectral Output
Optimum Spectrum and Pulse Shape for Vascular Lesion Treatment: The Science Behind MaxG James Childs, Ph.D.; Andrei Erofeev, Ph.D.; Mikhail Smirnov, Ph.D.; and Gregory Altshuler, Ph.D., Sc.D. Introduction
More informationInteresting Case Series. Aggressive Tumor of the Midface
Interesting Case Series Aggressive Tumor of the Midface Adrian Frunza, MD, Dragos Slavescu, MD, and Ioan Lascar, MD, PhD Bucharest Emergency Clinical Hospital, Bucharest University School of Medicine,
More informationTopical Diclofenac Gel, Fluorouracil Cream, Imiquimod Cream, and Ingenol Gel Prior Authorization with Quantity Limit Program Summary
Topical Diclofenac Gel, Fluorouracil Cream, Imiquimod Cream, and Ingenol Gel Prior Authorization with Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1-8 Topical Diclofenac Gel Indication
More informationTherapeutic Efficacy and Safety of Wavelength-Converted 660-nm Q-Switched Ruby-Like Versatile YAG Treatment on Various Skin Pigmentation Disorders
OA() Med Laser Epub 2014 July 14 pissn 2287-8300ㆍeISSN 2288-0224 Therapeutic Efficacy and Safety of Wavelength-Converted 660-nm Q-Switched Ruby-Like Versatile YAG Treatment on Various Skin Pigmentation
More informationMING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1)
Curettage prior to Mohs Micrographic Surgery for Previously Biopsied Nonmelanoma Skin Cancers: What Are We Curetting? Retrospective, Prospective, and Comparative Study MING H. JIH, MD,PHD, PAUL M. FRIEDMAN,
More informationINTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON
22 COPYRIGHT 2007 INTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON Martin Braun MD Vancouver Laser & Skin Care Centre Inc, Vancouver,
More informationCitation The Journal of Dermatology, 37(8), available at
NAOSITE: Nagasaki University's Ac Title Two cases of blaschkitis with promi Author(s) Utani, Atsushi Citation The Journal of Dermatology, 37(8), Issue Date 2010-08 URL Right http://hdl.handle.net/10069/25634
More informationالاكزيماتيد= Eczematid
1 / 7 2 / 7 Pityriasis Debate confusing of hypopigmentation characterized increasing surrounded differ hypomelanotic "progressive exists alba misnomer extensive a to observed term the applied term derived
More informationBBLs BroadBand Light. Daryl Mossburg, RN BSN Clinical Specialist Sciton, Inc. All rights reserved.
BBLs BroadBand Light Daryl Mossburg, RN BSN Clinical Specialist 1 2009 Sciton, Inc. All rights reserved. BBL - BroadBand Light BBL module incorporated into JOULE BBLs Standalone System 2 2009 Sciton, Inc.
More informationNHS. Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions)
NHS National Institute for Health and Clinical Excellence Issue date: February 2006 Photodynamic therapy for non-melanoma skin (including premalignant and primary non-metastatic skin lesions) Understanding
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationDermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial
Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial Cutaneous Oncology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI
More informationAdvances in Lasers for Skin of Color
Review Advances in Lasers for Skin of Color Heather Woolery-Lloyd, MD; Mohamed L. Elsaie, MD, MBA The popularity of cutaneous laser surgery has soared; however, the use of lasers in patients with skin
More informationTreatment of Refractory Rosacea with a Dual Wavelength Long- Pulsed 755-nm Alexandrite and 1,064-nm Nd:YAG Laser
Med Laser 2018;7(1):47-51 https://doi.org/10.25289/ml.2018.7.1.47 pissn 2287-8300 ㆍ eissn 2288-0224 Treatment of Refractory Rosacea with a Dual Wavelength Long- Pulsed 755-nm Alexandrite and 1,064-nm Nd:YAG
More informationF024: Photodynamic Therapy in Medical and Aesthetic Dermatology
F024: Photodynamic Therapy in Medical and Aesthetic Dermatology Improving Efficacy and Maintaining Safety of ALA-PDT American Academy of Dermatology 76 th Annual Meeting San Diego, CA Maria M. Tsoukas,
More informationKLERESCA ACNE TREATMENT NO MORE HIDING. Using fluorescent light energy to treat your acne
KLERESCA ACNE TREATMENT NO MORE HIDING Using fluorescent light energy to treat your acne Introducing a new technology that boosts your own healing mechanisms 1-8 Non-invasive treatment Using fluorescent
More informationJAM ACAD DERMATOL VOLUME 76, NUMBER 2. Research Letters 351
JAM ACAD DERMATOL Research Letters 351 Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes To the Editor:
More informationA Retrospective Study on the Risk of Non-Melanoma Skin Cancer in PUVA and Narrowband UVB Treated Patients
Volume 1, Issue 3 Research Article A Retrospective Study on the Risk of Non-Melanoma Skin Cancer in PUVA and Narrowband UVB Treated Patients Darukarnphut P, Rattanakaemakorn P *, Rajatanavin N Division
More informationLARYNGEAL DYSPLASIA. Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital
LARYNGEAL DYSPLASIA Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital INTRODUCTION Laryngeal cancer constitutes 1-2% of all malignancies diagnosed worldwide Survival is related
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationBISON. Accento. 755nm Long Pulsed Alexandrite Laser 1064nm Long Pulsed Nd:YAG Laser FOR EXPORT ONLY
BISON D www.bisonmedical.com U A ong Pulsed Alexandrite aser 1064nm ong Pulsed Nd:YAG aser S I N G E ong Pulsed Alexandrite aser FOR EXPORT ONY Dual & Single D U A & 1064nm Dual Wavelength aser ong Pulsed
More information